Pembroke & Partners LLC 13D and 13G filings for Matinas BioPharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 1:44 pm Purchase |
2025-04-08 | 13D | Matinas BioPharma Holdings, Inc. MTNB |
Pembroke & Partners LLC | 16,895,712 9.990% |
15,877,324 (+1559.06%) |
Filing |
| 2025-02-21 3:11 pm Purchase |
2025-02-13 | 13D | Matinas BioPharma Holdings, Inc. MTNB |
Pembroke & Partners LLC | 1,018,388 20.000% |
1,018,388 (New Position) |
Filing |